These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evidence for retrograde degeneration of epinephrine neurons in Alzheimer's disease. Burke WJ; Chung HD; Huang JS; Huang SS; Haring JH; Strong R; Marshall GL; Joh TH Ann Neurol; 1988 Oct; 24(4):532-6. PubMed ID: 3239955 [TBL] [Abstract][Full Text] [Related]
3. Evidence for decreased transport of PNMT protein in advanced Alzheimer's disease. Burke WJ; Chung HD; Marshall GL; Gillespie KN; Joh TH J Am Geriatr Soc; 1990 Dec; 38(12):1275-82. PubMed ID: 2254565 [TBL] [Abstract][Full Text] [Related]
4. Regional changes in phenylethanolamine-N-methyltransferase of rat brain during development. Díaz Borges JM; Rodríguez L; Urbina M J Neurosci Res; 1980; 5(4):363-7. PubMed ID: 7431437 [TBL] [Abstract][Full Text] [Related]
5. An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Sheu KF; Kim YT; Blass JP; Weksler ME Ann Neurol; 1985 May; 17(5):444-9. PubMed ID: 4004169 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the functional role of brain adrenergic neurons: chronic effects of phenylethanolamine N-methyltransferase inhibitors and alpha adrenergic receptor antagonists on brain norepinephrine metabolism. Stolk JM; Vantini G; Perry BD; Guchhait RB; U'Prichard DC J Pharmacol Exp Ther; 1984 Sep; 230(3):577-86. PubMed ID: 6147403 [TBL] [Abstract][Full Text] [Related]
7. Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. Mastrogiacoma F; Lindsay JG; Bettendorff L; Rice J; Kish SJ Ann Neurol; 1996 May; 39(5):592-8. PubMed ID: 8619544 [TBL] [Abstract][Full Text] [Related]
8. Loss of C1 and C3 epinephrine-synthesizing neurons in the medulla oblongata in Parkinson's disease. Gai WP; Geffen LB; Denoroy L; Blessing WW Ann Neurol; 1993 Apr; 33(4):357-67. PubMed ID: 8489206 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Bird TD; Stranahan S; Sumi SM; Raskind M Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients. Battaini F; Pascale A; Lucchi L; Pasinetti GM; Govoni S Exp Neurol; 1999 Oct; 159(2):559-64. PubMed ID: 10506528 [TBL] [Abstract][Full Text] [Related]
11. The effect of epinephrine on phenylethanolamine N-methyltransferase in cultured explants of adrenal medulla. Burke WJ; Davis JW; Joh TH; Reis DJ; Horenstein S; Bhagat BD Endocrinology; 1978 Aug; 103(2):358-67. PubMed ID: 744091 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and the alpha2-adrenoceptor. Grunewald GL; Dahanukar VH; Jalluri RK; Criscione KR J Med Chem; 1999 Jan; 42(1):118-34. PubMed ID: 9888838 [TBL] [Abstract][Full Text] [Related]
13. Effects of dexamethasone on phenylethanolamine N-methyl-transferase (PNMT) and adrenaline (A) in the brains of adult and neonatal rats. Moore KE; Phillipson OT Br J Pharmacol; 1975 Mar; 53(3):453P-454P. PubMed ID: 1137752 [No Abstract] [Full Text] [Related]
14. Phenylethanolamine-N-methyltransferase activity determines the epinephrine concentration of pheochromocytomas. Feldman JM Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):389-98. PubMed ID: 7323441 [TBL] [Abstract][Full Text] [Related]
15. Identification of phenylethanolamine N-methyltransferase gene expression in stellate ganglia and its modulation by stress. Kubovcakova L; Micutkova L; Bartosova Z; Sabban EL; Krizanova O; Kvetnansky R J Neurochem; 2006 Jun; 97(5):1419-30. PubMed ID: 16696852 [TBL] [Abstract][Full Text] [Related]
16. Phenylethanolamine N-methyltransferase activity in human brains. Trocewicz J; Oka K; Nagatsu T; Nagatsu I; Iizuka R; Narabayashi H Biochem Med; 1982 Jun; 27(3):317-24. PubMed ID: 7115364 [No Abstract] [Full Text] [Related]
17. Stressor specificity and effect of prior experience on catecholamine biosynthetic enzyme phenylethanolamine N-methyltransferase. Kvetnansky R Ann N Y Acad Sci; 2004 Dec; 1032():117-29. PubMed ID: 15677399 [TBL] [Abstract][Full Text] [Related]
18. Identification of epinephrine and phenylethanolamine N-methyltransferase activity in rat retina. Cohen J; Hadjiconstantinou M Fed Proc; 1984 Sep; 43(12):2725-8. PubMed ID: 6468670 [TBL] [Abstract][Full Text] [Related]
19. Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Kuhla B; Boeck K; Schmidt A; Ogunlade V; Arendt T; Münch G; Lüth HJ Neurobiol Aging; 2007 Jan; 28(1):29-41. PubMed ID: 16427160 [TBL] [Abstract][Full Text] [Related]
20. Reduced homocysteine-thiolactonase activity in Alzheimer's disease. Suszynska J; Tisonczyk J; Lee HG; Smith MA; Jakubowski H J Alzheimers Dis; 2010; 19(4):1177-83. PubMed ID: 20308784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]